Harrow (NasdaqGM:HROW) Q4 2025 Earnings call March 03, 2026 08:00 AM ET Company ParticipantsAmir Shojaei - Chief Scientific OfficerAndrew Boll - President and CFOJeffrey Cohen - Managing Director and Director of Equity ResearchMark Baum - CEOMayank Mamtani - Senior Managing Director and Group Head of HealthcareMike Biega - VP of Investor Relations and CommunicationsPatrick Sullivan - Chief Commercial OfficerThomas Schrader - Managing DirectorTimur Ivannikov - Biotechnology Research AssociateConference Call ...